John Z. Ayanian, MD (Harvard Medical School), MPP (Kennedy School of Government); Professor of Health Policy and Management; Professor of Medicine and Health Care Policy, Harvard Medical School. Access to care; quality of care; cardiovascular disease; cancer; primary and specialty care; health care disparities.
David W. Bates, MD (Johns Hopkins Medical School), MSc (HSPH); Professor of Medicine and Health Care Policy. Safety, quality, informatics, improving safety and quality using information technology, primary care.
Maureen Bisognano, MS (Boston University), Instructor in Health Policy and Management, Executive Vice President and COO, Institute for Healthcare Improvement. Quality improvement in healthcare; strategic planning; leadership.
Roger B. Davis, MA (University of Rochester), ScD (Harvard University); Associate Professor in the Department of Biostatistics. Associate Professor of Medicine, Harvard Medical School. Design and analysis of clinical trials; recursive partitioning methods; collaboration with medical investigators; health services research.
Jonathan Einbinder, MD (Columbia P&S), MPH (HSPH); Corporate Manager for Quality Data Management, Partners HealthCare System. Practicing general internist at Brigham and Women’s Hospital. Measuring and improving quality using information systems, with a particular focus on data warehousing, population registries, and clinical dashboards.
Arnold M. Epstein, MA (Harvard University), MD (Duke University); John H. Foster Professor and Chair, Department of Health Policy and Management, Professor of Medicine, Harvard Medical School. Quality of care and disparities in care for disadvantaged populations.
Garrett M. Fitzmaurice, ScD (Harvard University); Associate Professor in the Department of Biostatistics; Associate Professor of Psychiatry, Harvard Medical School. Design and analysis of longitudinal and repeated measures studies; missing data methods; collaboration with medical investigators.
Richard D. Gelber, MS (Stanford University), PhD (Cornell University); Professor of Pediatrics (Biostatistics), Harvard Medical School. Design and analysis of clinical trials; quality of life endpoints for clinical trials; statistical education of medical professionals.
Rose Goldman, MD (Yale University) MPH ( Harvard School of Public Health); Associate Professor in the Department of Environmental Health, HSPH; Associate Professor of Medicine at Harvard Medical School; co-project director of the New England Pediatric Environmental Health Specialty Unit at Cambridge Hospital and Children's Hospital, Boston. Repetitive Strain injuries, neurotoxicity, metals, pediatric environmental health, and teaching of Environmental and Occupational Medicine.
Albert Hofman, MD (University of Groningen), PhD (Erasmus University); Adjunct Professor, Department of Epidemiology. Incidence and risk factors of Alzheimer’s disease, vascular dementia, Parkinson’s disease and Creutzfeld-Jakob disease. Determinants of atherosclerosis, heart disease and stroke.
M.G. Myriam Hunink, MD (University of Leiden), PhD (Erasmus University Rotterdam), Professor of Clinical Epidemiology and Radiology at the Erasmus University Medical Center Rotterdam, the Netherlands and Adjunct Professor of Health Policy at the Harvard School of Public Health, Boston. Research focuses on the assessment of diagnostic imaging and image-guided therapeutic technologies, using techniques from clinical epidemiology, meta-analysis, decision modeling, and cost-effectiveness analysis. Main interest is in the evaluation of technologies for the management of cardiovascular disease. Methodological issues of special interest are the design of studies for the evaluation of diagnostic imaging and stochastic modeling.
Hongyu Jiang, PhD (University of Wisconsin-Madison); Assistant Professor of Biostatistics, Harvard School of Public Health. Statistical methods for correlated multivariate time-to-event data and censored medical cost data; resistance cost quantification of antiretroviral therapies; family-based association test for quantitative traits.
Ichiro Kawachi, MD, PhD (University of Otago), DipCommH (College of Community Medicine of New Zealand); Professor of Social Epidemiology, Department of Society, Human Development, and Health. Social inequalities in health, especially related to income distribution; stress and cardiovascular disease; quality of life and healthy aging; tobacco control.
Molly Kile, MS ScD (Harvard School of Public Health); Research Fellow in the Department of Environmental Health, HSPH Exposure assessment; environmental epidemiology; risk assessment; specializing in metals and issues related to drinking water quality.
Anthony Komaroff, MD (University of Washington); Simcox-Clifford-Higby Professor of Medicine, Harvard Medical School. Clinical epidemiologic studies of common problems in primary care; computer systems in medical care. Publishing of medical information for the public.
Francine Laden, ScD (Harvard University), Assistant Professor of Environmental Epidemiology, Harvard School of Public Health; Assistant Professor of Medicine (Epidemiology), Harvard Medical School. Epidemiologic studies of environmental risk factors, including exposure to air pollution and persistent organic pollutants, and risk of cancer, mortality, and chronic respiratory and cardiovascular disease.
Michelle Mello, MPhil (Oxford University), PhD (University of North Carolina), JD (Yale University); C. Boyden Gray Associate Professor of Health Policy and Law. Public health law and ethics; research ethics; medical malpractice; medical errors and patient safety; mass tort litigation.
Blackford Middleton, MD (SUNY-Buffalo), MPH (Yale), MSc (Stanford). Corporate Director of Clinical Informatics Research & Development, Chairman, Center for IT Leadership, Partners HealthCare System; Design and implementation of integrated clinical information systems, special focus on electronic health records, clinical decision support, technology assessment, and patient-centered informatics.
Murray A. Mittleman, MD, CM (McGill University), MPH, DPH (Harvard University); Associate Professor in the Department of Epidemiology; Associate Professor of Medicine, Harvard Medical School. Epidemiologic methods; cardiovascular epidemiology; stress and heart disease; injury epidemiology.
Marc J. Roberts, PhD (Harvard University); Professor of Political Economy. Health policy; environmental policy; ethical aspects of allocating scarce public health resources; health sector reform in Asia and the Middle East.
Meredith Rosenthal, PhD (Health Economics, Harvard); Associate Professor of Health Economics and Policy Health economics, U.S. health policy, payment incentives, consumer-directed health plans, pharmaceutical industry.
Donald C. Simonson, MD, MBA, MPH, ScD (Yale, MIT, Harvard); Lecturer on Medicine, Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School. Research interests include clinical pathophysiology and treatment of diabetes and related metabolic disorders, health outcomes research, disease management and health economics.
Kenneth E. Stanley, MA (Bucknell University), PhD (University of Florida); Lecturer on Biostatistics. Clinical trials; clinical and natural history research in HIV disease, estimating mortality attributable to tobacco in the presence of incomplete information.
Michael Stoto, PhD (Statistics, Harvard);Adjunct Professor of Biostatistics and Director, Evaluation Core, Center for Public Health Preparedness Harvard School of Public Health Professor of Health Services Administration and Population Health Georgetown University School of Nursing & Health Studies
David Studdert, LLB (University of Melbourne), MPH, ScD (Harvard School of Public Health); Federation Fellow and Professor, University of Melbourne, Australia. Health law and regulation; medical malpractice, medical injuries, and quality of care; dispute resolution; medical ethics.
Marcia A. Testa, MPH, MPhil, PhD (Yale University); Senior lecturer on Biostatistics. Applied areas of research involve evaluating quality of life and health economic outcomes in therapeutic clinical trials and quality of care research and quantifying and evaluating public health preparedness in relation to bioterrorism, counterterrorism, emerging infections and natural disasters; Methodological research includes measurement of latent constructs, structural equation modeling, the analysis of multiple endpoints and large database analytical algorithms.
Milton C. Weinstein, AM, MPP, PhD (Harvard University); Henry J. Kaiser Professor of Health Policy and Management (Health Policy and Management and Biostatistics); Professor of Medicine, Harvard Medical School. Cost-effectiveness of health practices and technologies.